InflaRx NV (IFRX)
1.61
+0.16
(+11.03%)
USD |
NASDAQ |
May 17, 16:00
1.61
0.00 (0.00%)
After-Hours: 20:00
InflaRx Free Cash Flow: -45.89M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -45.89M |
| December 31, 2023 | -41.02M |
| September 30, 2023 | -36.38M |
| June 30, 2023 | -32.41M |
| March 31, 2023 | -32.62M |
| December 31, 2022 | -35.76M |
| September 30, 2022 | -42.76M |
| June 30, 2022 | -52.30M |
| March 31, 2022 | -49.17M |
| December 31, 2021 | -47.30M |
| September 30, 2021 | -43.67M |
| June 30, 2021 | -43.74M |
| March 31, 2021 | -42.75M |
| Date | Value |
|---|---|
| December 31, 2020 | -41.82M |
| September 30, 2020 | -49.76M |
| June 30, 2020 | -47.53M |
| March 31, 2020 | -50.73M |
| December 31, 2019 | -49.03M |
| September 30, 2019 | -38.77M |
| June 30, 2019 | -34.26M |
| March 31, 2019 | -29.16M |
| December 31, 2018 | -26.40M |
| September 30, 2018 | -22.26M |
| June 30, 2018 | -21.88M |
| March 31, 2018 | -18.18M |
| December 31, 2017 | -13.93M |
Free Cash Flow Range, Past 5 Years
-52.30M
Minimum
Jun 2022
-32.41M
Maximum
Jun 2023
-42.88M
Average
-43.22M
Median
Free Cash Flow Benchmarks
| Affimed NV | -123.42M |
| MorphoSys AG | -- |
| BioNTech SE | 5.344B |
| Immatics NV | -29.05M |
| CureVac NV | -349.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -16.15M |
| Cash from Investing (Quarterly) | 29.27M |
| Cash from Financing (Quarterly) | -0.0931M |
| Free Cash Flow Per Share (Quarterly) | -0.2746 |
| Free Cash Flow to Equity (Quarterly) | -16.17M |
| Free Cash Flow to Firm (Quarterly) | -16.17M |
| Free Cash Flow Yield | -48.78% |